Recurrent atrial tachycardia and atrial fibrillation after circumferential pulmonary vein ablation: What's the difference?

复发性房性心动过速，后环肺静脉消融房颤：有什么区别？

youdao

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.

FORBES: Rivaroxaban Gains FDA Indications For The Treatment And Prevention Of DVT And PE